2. Academic Validation
  3. Probing the isoprenylcysteine carboxyl methyltransferase (Icmt) binding pocket: sulfonamide modified farnesyl cysteine (SMFC) analogs as Icmt inhibitors

Probing the isoprenylcysteine carboxyl methyltransferase (Icmt) binding pocket: sulfonamide modified farnesyl cysteine (SMFC) analogs as Icmt inhibitors

  • Bioorg Med Chem Lett. 2011 May 1;21(9):2616-20. doi: 10.1016/j.bmcl.2011.01.078.
Jaimeen D Majmudar 1,  Kalub Hahne,  Christine A Hrycyna,  Richard A Gibbs
Affiliations

Affiliation

  • 1 Department of Medicinal Chemistry and Molecular Pharmacology and the Purdue University Center for Cancer Research, Purdue University, West Lafayette, IN 47907, USA.
PMID: 21334890 DOI: 10.1016/j.bmcl.2011.01.078
Abstract

Human isoprenylcysteine carboxyl methyltransferase (hIcmt) is a promising Anticancer target as it is important for the post-translational modification of oncogenic Ras proteins. We herein report the synthesis and biochemical activity of 41 farnesyl-cysteine based analogs versus hIcmt. We have demonstrated that the amide linkage of a hIcmt substrate can be replaced by a sulfonamide bond to achieve hIcmt inhibition. The most potent sulfonamide-modified farnesyl cysteine analog was 6ag with an IC(50) of 8.8±0.5 μM for hIcmt.

Figures
Products
  • Cat. No.
    Product Name
    Description
    Target
    Research Area
  • HY-149707
    ICMT抑制剂
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z